Evolution Energy Minerals Limited (ASX:EV1) Managing Director Phil Hoskins talks to David Tasker at the Future Facing Commodities Conference in Singapore.
Topics discussed include:
EV1's Tanzanian Graphite project;
the recent updated DFS;
the formal signing of framework agreement with the Tanzanian Government.
21 Jun 2021 - BluGlass Limited (ASX:BLG) Executive Chair, James Walker and Chief Technology and Operations Officer, Dr Ian Mann discuss the company's laser diode production and its recent rights issue.
11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
21 Dec 2023 - Dive into Laramide Resources' (ASX:LAM) uranium ventures with insights from Non-Executive Chairman John G Booth. He discusses flagship projects, grants and developments in Australia and the US.
30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
20 Aug 2021 - TALi Digital Limited (ASX:TD1) Managing Director Glenn Smith introduces the company’s software for the assessment and treatment of childhood attention difficulties and discusses the company's recent agreement with US company Akili.
17 Feb 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses financial conditions, the outlook for growth, central bank monetary policy, and what this means for portfolio construction.
01 May 2023 - James Powell, General Manager - Investor Relations, Corporate Affairs and Sustainability of Rural Funds Management, provides on update for the Rural Funds Group (ASX:RFF).
25 Oct 2024 - In the keynote address for the inaugural Semiconductor Australia conference, Digital Playground Co-Founder and General Partner Peter Barrett discusses Australia's potential to lead in next-generation technology.
31 Oct 2023 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company's drug candidates, highlighting promising data from the 2023 ESMO Congress.